IHE.US iShares U.S. Pharmaceuticals ETF
- Total assets
- 1.71B
- Expense ratio
- 0.41%
- Dividend yield
- 1.32%
- 1-year return
- +38.90%
- Holdings
- 52
- Since
- 2006
Fund data as reported by the issuer, updated Nov 15, 2026. Total assets are in the fund's base currency.
What does IHE.US invest in?
- Mostly US stocks (101.2%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (100.0%)
- Top 3 holdings: 54.8% of the fund
Asset allocation
- US stocks 101.2%
- Cash 0.1%
Top holdings
- Eli Lilly and Company 27.63%
- Johnson & Johnson 22.27%
- Royalty Pharma Plc 4.93%
- Viatris Inc 4.65%
- Zoetis Inc 4.61%
iShares U.S. Pharmaceuticals ETF performance
Sharpe ratio 1.30- This year
- +29.97%
- 1 year
- +38.90%
- 3 years
- +26.84%
- 5 years
- +12.86%
Volatility 16.5% over 1 year and 15.7% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
IHE.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About iShares U.S. Pharmaceuticals ETF
The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The fund is non-diversified.
Full fund profileiShares U.S. Pharmaceuticals ETF top holdings
82.9% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Eli Lilly and Company LLY.US | Healthcare | United States | 27.63% |
| Johnson & Johnson JNJ.US | Healthcare | United States | 22.27% |
| Royalty Pharma Plc RPRX.US | Healthcare | United States | 4.93% |
| Viatris Inc VTRS.US | Healthcare | United States | 4.65% |
| Zoetis Inc ZTS.US | Healthcare | United States | 4.61% |
| Pfizer Inc PFE.US | Healthcare | United States | 4.51% |
| Merck & Company Inc MRK.US | Healthcare | United States | 4.35% |
| Bristol-Myers Squibb Company BMY.US | Healthcare | United States | 4.01% |
| Jazz Pharmaceuticals PLC JAZZ.US | Healthcare | United States | 3.24% |
| Elanco Animal Health ELAN.US | Healthcare | United States | 2.70% |
The 10 largest of 52 holdings.
IHE.US sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
IHE.US regional exposure
- North America100.0%
Share of the stocks in the fund.
Company size
Average market cap 134B- Mega cap25.2%
- Big cap34.6%
- Medium cap14.4%
- Small cap12.7%
- Micro cap10.1%
iShares U.S. Pharmaceuticals ETF fund profile
- Fund name
- iShares U.S. Pharmaceuticals ETF
- Ticker
- IHE.US
- Exchange
- USA Stocks
- Issuer
- iShares
- Index tracked
- -
- Category
- Healthcare Equity
- Domicile
- United States
- Inception date
- May 1, 2006
- Trading currency
- USD
- Expense ratio
- 0.41%
- Annual turnover
- 0.4%
About iShares U.S. Pharmaceuticals ETF
The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The fund is non-diversified.